Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDS

The coronavirus pandemic continues to challenge global healthcare. Severely affected patients are often in need of high doses of analgesics and sedatives. The latter was studied in critically ill coronavirus disease 2019 (COVID-19) patients in this prospective monocentric analysis. COVID-19 acute re...

Full description

Bibliographic Details
Main Authors: Armin N. Flinspach, Hendrik Booke, Kai Zacharowski, Ümniye Balaban, Eva Herrmann, Elisabeth H. Adam
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/3/588
_version_ 1797487023197519872
author Armin N. Flinspach
Hendrik Booke
Kai Zacharowski
Ümniye Balaban
Eva Herrmann
Elisabeth H. Adam
author_facet Armin N. Flinspach
Hendrik Booke
Kai Zacharowski
Ümniye Balaban
Eva Herrmann
Elisabeth H. Adam
author_sort Armin N. Flinspach
collection DOAJ
description The coronavirus pandemic continues to challenge global healthcare. Severely affected patients are often in need of high doses of analgesics and sedatives. The latter was studied in critically ill coronavirus disease 2019 (COVID-19) patients in this prospective monocentric analysis. COVID-19 acute respiratory distress syndrome (ARDS) patients admitted between 1 April and 1 December 2020 were enrolled in the study. A statistical analysis of impeded sedation using mixed-effect linear regression models was performed. Overall, 114 patients were enrolled, requiring unusual high levels of sedatives. During 67.9% of the observation period, a combination of sedatives was required in addition to continuous analgesia. During ARDS therapy, 85.1% (<i>n</i> = 97) underwent prone positioning. Veno-venous extracorporeal membrane oxygenation (vv-ECMO) was required in 20.2% (<i>n</i> = 23) of all patients. vv-ECMO patients showed significantly higher sedation needs (<i>p</i> < 0.001). Patients with hepatic (<i>p</i> = 0.01) or renal (<i>p</i> = 0.01) dysfunction showed significantly lower sedation requirements. Except for patient age (<i>p</i> = 0.01), we could not find any significant influence of pre-existing conditions. Age, vv-ECMO therapy and additional organ failure could be demonstrated as factors influencing sedation needs. Young patients and those receiving vv-ECMO usually require increased sedation for intensive care therapy. However, further studies are needed to elucidate the causes and mechanisms of impeded sedation.
first_indexed 2024-03-09T23:41:44Z
format Article
id doaj.art-47d9409cce224d0bada8ea05cb987296
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T23:41:44Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-47d9409cce224d0bada8ea05cb9872962023-11-23T16:50:49ZengMDPI AGJournal of Clinical Medicine2077-03832022-01-0111358810.3390/jcm11030588Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDSArmin N. Flinspach0Hendrik Booke1Kai Zacharowski2Ümniye Balaban3Eva Herrmann4Elisabeth H. Adam5Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, Goethe-University Frankfurt, 60590 Frankfurt/Main, GermanyDepartment of Anaesthesiology, Intensive Care Medicine and Pain Therapy, Goethe-University Frankfurt, 60590 Frankfurt/Main, GermanyDepartment of Anaesthesiology, Intensive Care Medicine and Pain Therapy, Goethe-University Frankfurt, 60590 Frankfurt/Main, GermanyDepartment of Biostatistics and Mathematical Modelling, Goethe-University Frankfurt, 60590 Frankfurt/Main, GermanyDepartment of Biostatistics and Mathematical Modelling, Goethe-University Frankfurt, 60590 Frankfurt/Main, GermanyDepartment of Anaesthesiology, Intensive Care Medicine and Pain Therapy, Goethe-University Frankfurt, 60590 Frankfurt/Main, GermanyThe coronavirus pandemic continues to challenge global healthcare. Severely affected patients are often in need of high doses of analgesics and sedatives. The latter was studied in critically ill coronavirus disease 2019 (COVID-19) patients in this prospective monocentric analysis. COVID-19 acute respiratory distress syndrome (ARDS) patients admitted between 1 April and 1 December 2020 were enrolled in the study. A statistical analysis of impeded sedation using mixed-effect linear regression models was performed. Overall, 114 patients were enrolled, requiring unusual high levels of sedatives. During 67.9% of the observation period, a combination of sedatives was required in addition to continuous analgesia. During ARDS therapy, 85.1% (<i>n</i> = 97) underwent prone positioning. Veno-venous extracorporeal membrane oxygenation (vv-ECMO) was required in 20.2% (<i>n</i> = 23) of all patients. vv-ECMO patients showed significantly higher sedation needs (<i>p</i> < 0.001). Patients with hepatic (<i>p</i> = 0.01) or renal (<i>p</i> = 0.01) dysfunction showed significantly lower sedation requirements. Except for patient age (<i>p</i> = 0.01), we could not find any significant influence of pre-existing conditions. Age, vv-ECMO therapy and additional organ failure could be demonstrated as factors influencing sedation needs. Young patients and those receiving vv-ECMO usually require increased sedation for intensive care therapy. However, further studies are needed to elucidate the causes and mechanisms of impeded sedation.https://www.mdpi.com/2077-0383/11/3/588critical carehypnotics and sedativesacute respiratory distress syndromesevere acute respiratory syndrome coronavirus 2pulmonary ventilationprone position
spellingShingle Armin N. Flinspach
Hendrik Booke
Kai Zacharowski
Ümniye Balaban
Eva Herrmann
Elisabeth H. Adam
Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDS
Journal of Clinical Medicine
critical care
hypnotics and sedatives
acute respiratory distress syndrome
severe acute respiratory syndrome coronavirus 2
pulmonary ventilation
prone position
title Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDS
title_full Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDS
title_fullStr Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDS
title_full_unstemmed Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDS
title_short Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDS
title_sort associated factors of high sedative requirements within patients with moderate to severe covid 19 ards
topic critical care
hypnotics and sedatives
acute respiratory distress syndrome
severe acute respiratory syndrome coronavirus 2
pulmonary ventilation
prone position
url https://www.mdpi.com/2077-0383/11/3/588
work_keys_str_mv AT arminnflinspach associatedfactorsofhighsedativerequirementswithinpatientswithmoderatetoseverecovid19ards
AT hendrikbooke associatedfactorsofhighsedativerequirementswithinpatientswithmoderatetoseverecovid19ards
AT kaizacharowski associatedfactorsofhighsedativerequirementswithinpatientswithmoderatetoseverecovid19ards
AT umniyebalaban associatedfactorsofhighsedativerequirementswithinpatientswithmoderatetoseverecovid19ards
AT evaherrmann associatedfactorsofhighsedativerequirementswithinpatientswithmoderatetoseverecovid19ards
AT elisabethhadam associatedfactorsofhighsedativerequirementswithinpatientswithmoderatetoseverecovid19ards